MAPT and Alzheimer disease: Moreover, immunoreactivity with AD-diagnostic antibodies PHF1, Alz50, and TG3 [13-15] were found in DG granule cells of AD patients, pointing to a clinical relevance of the mossy fiber pathway to Tau-related disease progression.